Skip to content

Seaport Therapeutics SPTX Short-Term Investments

Short-Term Investments at other companies

SSR Mining logo
SSR MiningSSRM
$40.27M+85.8%
Repligen logo
RepligenRGEN
$201.88M
Chime Financial, Inc. Class A Common Stock logo
Chime Financial, Inc. Class A Common StockCHYM
$403.61M
Alignment Healthcare logo
Alignment HealthcareALHC
$20.71M-37.9%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$664.33M+313%
Kulicke & Soffa Industries logo
Kulicke & Soffa IndustriesKLIC
$150M-49.2%

Other financials

Income statement

See full
Operating income-$27.5M-70.2%
Net income-$25.4M-93.6%
EPS (diluted)-$10.34-83.0%

Balance sheet

See full
Cash & equivalents$52.9M
Total debt$5.3M
Total equity-$115.6M-220%
Total assets$227.7M

Cash flow

See full
Operating cash flow-$20.2M+0.2%
CapEx--100%
Free cash flow-$20.2M+0.4%

Valuation

See full
Market cap$972.65M
Enterprise value$925.08M

Returns & leverage

See full
Debt / equity-0×
Current ratio13.2×

Where this comes from

Reported directly by Seaport Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ShortTermInvestments.

The official record: Seaport Therapeutics ’s 10-Q, filed June 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Seaport Therapeutics 's short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Seaport Therapeutics 's short-term investments?
Seaport Therapeutics (SPTX) reported short-term investments of $129.7M in Q1 2026.
What does short-term investments mean?
Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.